Financial Performance - The company's operating revenue for Q1 2025 was ¥491,623,134.65, a decrease of 16.20% compared to ¥586,677,653.53 in the same period last year[4] - Net profit attributable to shareholders was ¥96,598,207.31, down 37.39% from ¥154,291,020.51 year-on-year[4] - Basic and diluted earnings per share decreased by 36.59%, from ¥0.41 to ¥0.26[4] - The decline in net profit was primarily due to a continuous drop in the market price of functional silanes and a decrease in product sales volume by 4.28% year-on-year[7] - Operating revenue for Q1 2025 was CNY 491,623,134.65, a decrease of 16.2% compared to CNY 586,677,653.53 in Q1 2024[16] - Net profit for Q1 2025 was CNY 96,598,207.31, down 37.4% from CNY 154,291,020.51 in Q1 2024[16][17] - The company's basic earnings per share for Q1 2025 were CNY 0.26, a decrease from CNY 0.41 in Q1 2024[17] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 165.72%, reaching ¥71,068,031.96, compared to ¥26,745,140.80 in the previous year[4] - The company's cash flow from operating activities generated a net cash inflow of CNY 71,068,031.96 in Q1 2025, significantly higher than CNY 26,745,140.80 in Q1 2024[20] - The company's cash and cash equivalents increased to CNY 3,414,301,098.77 as of March 31, 2025, compared to CNY 3,320,065,511.65 at the end of 2024, reflecting a growth of 2.8%[13] - Total cash and cash equivalents at the end of the period reached CNY 1,062,655,331.65, up from CNY 713,021,844.51 previously[21] - The company reported a significant increase in cash and cash equivalents by CNY 94,243,284.12, contrasting with a decrease of CNY 1,106,118,874.69 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,528,992,641.70, an increase of 4.08% from ¥5,312,107,967.19 at the end of the previous year[5] - The company's total assets increased to CNY 5,528,992,641.70 as of March 31, 2025, up from CNY 5,312,107,967.19 at the end of 2024, representing a growth of approximately 4.1%[13][15] - The company's accounts receivable rose to CNY 354,367,407.70 as of March 31, 2025, up from CNY 275,212,183.99 at the end of 2024, indicating a growth of 28.6%[13] - The company's total liabilities increased to CNY 483,063,699.09 as of March 31, 2025, compared to CNY 363,614,139.74 at the end of 2024, representing a growth of 32.8%[14][15] Shareholder Information - The company had a total of 20,464 common shareholders at the end of the reporting period[9] - Shareholders' equity attributable to the parent company rose by 1.97%, reaching ¥5,045,928,942.61 compared to ¥4,948,493,827.45 at the end of the previous year[5] Research and Development - Research and development expenses for Q1 2025 were CNY 14,993,234.33, down 24.1% from CNY 19,742,008.86 in Q1 2024[16] Financial Activities - The company reported a decrease in financial income, with a net financial expense of CNY -22,535,382.62 in Q1 2025 compared to CNY -18,469,887.28 in Q1 2024[16] - The net cash inflow from investment activities was CNY 18,117,882.43, a significant improvement compared to a net outflow of CNY 1,085,707,878.91 in the previous period[21] - Cash inflow from financing activities was CNY 7,697.00, while cash outflow amounted to CNY 50,138,179.88, resulting in a net cash flow of -CNY 50,130,482.88[21] Accounting Standards - The company plans to implement new accounting standards starting from 2025, which may affect the financial statements[21]
江瀚新材(603281) - 2025 Q1 - 季度财报